GHB and Drug-Facilitated Sexual Assault: What Every Responder Needs to Know

---

Ask a room of responders to name the drugs used to facilitate sexual assault and you will likely hear GHB and Rohypnol first, every time.

Now look at the toxicology data. In a study of 1,000 suspected drug-facilitated sexual assault cases spanning 37 states, the substances detected were ethanol (30.9%), cannabinoids (28.8%), amphetamine or methamphetamine (16.5%), cocaine or its metabolites (10.4%), and clonazepam (7.6%). An NIJ-funded study of 144 complainants found drugs in 61.8% of subjects — but only 4.9% were positive for flunitrazepam or GHB.

The National Institute of Justice states it plainly in its review of toxicological evidence: alcohol is the predominant substance in these cases, and GHB and Rohypnol are rarely detected.

This gap between reputation and reality is where cases get lost.

Alcohol Is the Drug

EVAWI’s own training materials have said this for years: the most common drug used to facilitate sexual assault is alcohol.

Sometimes offenders administer it deliberately. In research on undetected rapists, a majority of sexually aggressive college men reported obtaining sex by providing drugs or alcohol, and a substantial majority relied on intoxication rather than overt physical force. Often the victim drank voluntarily, and an offender selected them because of it.

The practical consequence: if your investigative reflex on a suspected drug-facilitated case is to chase an unusual drug, you are looking away from the most likely and most provable mechanism in the case.

Blackout is the piece most often misunderstood. Alcohol-induced blackout is a disruption of the hippocampus that blocks the formation of new long-term memories. Short-term memory and pre-existing memories remain intact. This means a person in blackout can hold a conversation, walk, answer questions, use a phone, and appear to be functioning — and retain nothing of it afterward.

Two things follow. First, a witness who says “she seemed fine” is not contradicting the victim’s memory loss; both can be accurate. Second, the fact that a victim engaged in apparently purposeful behavior tells you nothing about her capacity to consent. This is exactly the ground on which the consent defense is built in these cases, and it is answerable — but only by someone who understands the mechanism.

Why GHB Is Almost Never Proven

GHB deserves specific attention, not because it is common, but because when it is involved the window to prove it is so narrow that most cases fail on timing alone.

The pharmacology. GHB takes effect within roughly 15 to 30 minutes and its effects last 3 to 6 hours. Effects are steeply dose-dependent. In emergency department series, roughly three-quarters of GHB cases involved alcohol as well.

The detection window. EVAWI’s training bulletin on GHB testing puts it at approximately 4 hours in blood and 12 hours in urine. The forensic standard for drug-facilitated crime testing (ANSI/ASB Standard 121) provides that GHB urine testing is not required if more than 12 hours have elapsed.

Compare that to the general collection windows. Urine for a drug-facilitated crime panel should be collected within 120 hours and blood within 24 hours. Detection windows for most substances of interest run one to four days in urine, and hair analysis can reach back 90 days or more.

For GHB, you have hours, not days.

This is why “the tox screen came back negative” is such a dangerous piece of information in a GHB case. It usually means the sample was collected outside the window.

What Responders May Actually See

The symptom picture across guidance sources is consistent: drowsiness, dizziness, loss of muscle control, slurred speech, decreased inhibitions, memory loss or impairment, loss of consciousness, and vomiting. The National Protocol adds fatigue, light-headedness, physiologic instability, impaired motor skills, and severe intoxication, and notes that a patient’s own lack of recollection is itself a reason to screen. EVAWI’s guidance for first responders directs officers to ask specifically about loss of memory, disorientation, severe illness, and hallucinations.

The Collection Problem Nobody Warns You About

Here is a detail from EVAWI’s first responder guidance that has cost real cases: many sexual assault evidence kits do not contain a urine specimen container.

If your agency has no protocol for what to do about that, the answer defaults to nothing being collected.

The specifics, from the SOFT fact sheet and the National Protocol:

• Urine: collect as soon as possible, ideally within 120 hours. The National Protocol calls for at least 30 mL and preferably 100 mL. Preserve with sodium fluoride and refrigerate.
• Blood: collect within 24 hours. At least 20 mL per the National Protocol; grey-top tube (sodium fluoride and potassium oxalate); refrigerate.
• The first available void is the most valuable sample in a suspected GHB case. Do not wait for it to be convenient.
• Document collection time precisely, and document the reported time of ingestion or of the assault. Without both, a toxicologist cannot interpret the result.

What Good Practice Looks Like

• Ask every sexual assault victim about memory gaps, disorientation, unexpected severe illness, and hallucinations.
• Collect urine early and blood if you are within 24 hours — and confirm your kits have containers.
• Have a named toxicologist or lab contact before you need one, and know what their panel covers and at what limits.
• Tell victims explicitly that you are not investigating their substance use.
• Build the timeline through witnesses, receipts, rideshare records, door access logs, and video, rather than relying on the victim to fill gaps they cannot fill. Avoid leading questions across a memory gap; a compliant answer to a suggestive question is worse than no answer.
• Treat blackout as a documentable phenomenon requiring expert explanation at trial, not as a hole in the case.
• Write your report so that absent toxicology findings cannot be misread as evidence of no assault.

Learn More

---